Recent research focusing on Semaglutide at a dosage of 30mg is shedding new light on its potential benefits. Early findings suggest that this higher dosage may enhance the drug's ability to manage blood levels, potentially offering greater outcomes for individuals with type 2 diabetes. Further investigation is underway to fully understand the long-